To determine force readiness through the use of serological and RNA assays for SARS-CoV-2 and other respiratory pathogens.
No treatment. SARS-CoV-2 antibody testing, neutralizing antibody testing and testing for 22 respiratory pathogens including SARS-CoV-2.
Biofire® Fim Array® Respiratory (RP2plus) Panels, FimArray Bio-agent system (Biofire, Diagnostics, Salt Lake City, Utah)
Roche Elecsys Anti-SARS-CoV-2 assay on the Roche Cobas e System of IgG and IgM; neutralizing antibodies to be conducted via standard Virus Neutralization Test or high sensitivity and specificity commercial Surrogate Virus Neutralization Test.